UA101385C2 - Иммунологическая композиция, которая в качестве адъюванты содержит сульфолипо-циклодекстрин (sl-cd) и сапонин - Google Patents

Иммунологическая композиция, которая в качестве адъюванты содержит сульфолипо-циклодекстрин (sl-cd) и сапонин

Info

Publication number
UA101385C2
UA101385C2 UAA201101661A UAA201101661A UA101385C2 UA 101385 C2 UA101385 C2 UA 101385C2 UA A201101661 A UAA201101661 A UA A201101661A UA A201101661 A UAA201101661 A UA A201101661A UA 101385 C2 UA101385 C2 UA 101385C2
Authority
UA
Ukraine
Prior art keywords
cyclodextrin
antigen
immunological compositions
methods
sulpholipo
Prior art date
Application number
UAA201101661A
Other languages
English (en)
Ukrainian (uk)
Inventor
Філіп Ральф Легрбач
Вілліам Джон Чешір
Цзісянь Сінь
Original Assignee
Вайет Ллк
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2008904261A external-priority patent/AU2008904261A0/en
Application filed by Вайет Ллк filed Critical Вайет Ллк
Publication of UA101385C2 publication Critical patent/UA101385C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/724Cyclodextrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55577Saponins; Quil A; QS21; ISCOMS
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55583Polysaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)

Abstract

Заявленное изобретение касается иммунологических композиций, которые содержат сульфолипо-циклодекстрин (SL-CD) и сапонин, который является Quil А, и необязательно по крайней мере один антиген. Изобретение касается способов и иммунологических композиций, которые содержат по крайней мере один антиген, который может быть ветеринарным антигеном. Ветеринарный антиген в способах и иммунологических композициях изобретения может быть антигеном коров. Изобретение касается способов и иммунологических композиций, которые содержат рабдовирус коров (BEFV), вирус герпеса 1 коров (IBR) или вирус африканской катаральной лихорадки (BTV). Изобретение касается способа выявления иммунного ответа против BEFV, IBR или BTV у животного, которое заключается во введении животному композиции изобретения. В изобретении, в частности, иммунный ответ является защитным иммунным ответом. Изобретение касается способа приготовления иммунологической композиции, который заключается в добавлении Quil А к вирусу.
UAA201101661A 2008-08-19 2009-08-19 Иммунологическая композиция, которая в качестве адъюванты содержит сульфолипо-циклодекстрин (sl-cd) и сапонин UA101385C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2008904261A AU2008904261A0 (en) 2008-08-19 Immunological Composition
PCT/US2009/054285 WO2010022135A1 (en) 2008-08-19 2009-08-19 Immunological composition

Publications (1)

Publication Number Publication Date
UA101385C2 true UA101385C2 (ru) 2013-03-25

Family

ID=41696586

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201101661A UA101385C2 (ru) 2008-08-19 2009-08-19 Иммунологическая композиция, которая в качестве адъюванты содержит сульфолипо-циклодекстрин (sl-cd) и сапонин

Country Status (16)

Country Link
US (1) US20100047279A1 (ru)
EP (1) EP2331126A1 (ru)
JP (1) JP2012500282A (ru)
KR (1) KR101320141B1 (ru)
CN (1) CN102186502B (ru)
AR (1) AR076437A1 (ru)
AU (1) AU2009282581B2 (ru)
BR (1) BRPI0917290A8 (ru)
CA (1) CA2734654C (ru)
CO (1) CO6341568A2 (ru)
MX (1) MX2011001910A (ru)
RU (1) RU2506094C2 (ru)
TW (1) TW201010719A (ru)
UA (1) UA101385C2 (ru)
WO (1) WO2010022135A1 (ru)
ZA (1) ZA201102082B (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112012008185A2 (pt) * 2009-10-07 2016-08-16 Wyeth Llc composições que compreendem adjuvante, macrolídeo e antígeno proteináceo, e métodos para uso dessas composições
ES2617743T3 (es) * 2010-03-12 2017-06-19 Merial, Inc. Vacunas recombinantes del virus de la lengua azul y sus utilizaciones
US20140086961A1 (en) * 2011-05-09 2014-03-27 Universitat Autonoma De Barcelona Use of cyclodextrins in diets, water or vaccine adjuvants to boost the immune system of fish
CN103083658B (zh) * 2011-10-27 2015-09-02 普莱柯生物工程股份有限公司 一种用于治疗或预防猪感染性疾病的疫苗佐剂组合物
AU2014337452A1 (en) 2013-10-17 2016-04-21 Zoetis Services Llc Methods and compositions for treatment of S. equi infection
KR20170008850A (ko) * 2014-05-23 2017-01-24 피브로-애니멀 헬스 코포레이션 배합물, 조성물, 및 배합물 또는 조성물의 동물로의 투여 방법
BR102021012953A2 (pt) * 2021-06-29 2023-01-10 Fabp Biotech Desenvolvimento Em Biotecnologia Ltda. Composição de vacina veterinária contra helmintos, método para tratamento e prevenção de infecção causada por helmintos e uso

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK316188A (da) * 1987-06-15 1988-12-16 Duphar Int Res Sulfolipopolysaccharider som stimolatorer for den ikke specifikke forsvarsmekanisme
GB9622159D0 (en) * 1996-10-24 1996-12-18 Solvay Sociutu Anonyme Polyanionic polymers as adjuvants for mucosal immunization
US6645495B1 (en) * 1997-08-29 2003-11-11 Antigenics, Inc. Compositions of saponin adjuvants and excipients
US7049302B1 (en) * 1998-08-10 2006-05-23 Antigenics Inc. Compositions of CPG and saponin adjuvants and uses thereof
EP1104767A1 (en) * 1999-11-30 2001-06-06 Stichting Dienst Landbouwkundig Onderzoek Mono- and disaccharide derivatives containing both fatty acid ester and sulfate ester groups
CN1561389A (zh) * 2001-07-25 2005-01-05 纽约大学 糖基神经酰胺作为用于抗传染病和癌症的疫苗的佐剂的用途
CN1909925B (zh) * 2004-02-20 2010-10-13 中国农业大学 一种免疫佐剂
JP2008502605A (ja) * 2004-06-16 2008-01-31 スマート ドラッグ システムズ インコーポレイティド 徐放性ワクチン組成物
RU2288007C2 (ru) * 2005-02-17 2006-11-27 ГНУ ВНИИ ветеринарной вирусологии и микробиологии Способ изготовления ассоциированной инактивированной культуральной вакцины против инфекционного ринотрахеита и парагриппа-3 крупного рогатого скота

Also Published As

Publication number Publication date
RU2011105863A (ru) 2012-09-27
BRPI0917290A8 (pt) 2016-11-01
MX2011001910A (es) 2011-06-20
WO2010022135A1 (en) 2010-02-25
AU2009282581A1 (en) 2010-02-25
CO6341568A2 (es) 2011-11-21
TW201010719A (en) 2010-03-16
RU2506094C2 (ru) 2014-02-10
CN102186502B (zh) 2014-07-16
CA2734654C (en) 2015-02-10
US20100047279A1 (en) 2010-02-25
KR101320141B1 (ko) 2013-11-13
HK1157182A1 (en) 2012-06-29
KR20110044791A (ko) 2011-04-29
JP2012500282A (ja) 2012-01-05
CA2734654A1 (en) 2010-02-25
ZA201102082B (en) 2011-11-30
AU2009282581B2 (en) 2013-12-19
EP2331126A1 (en) 2011-06-15
AR076437A1 (es) 2011-06-15
CN102186502A (zh) 2011-09-14
BRPI0917290A2 (pt) 2015-11-10

Similar Documents

Publication Publication Date Title
MY150706A (en) Immunogenic substances comprising a polyinosinic acid-polycytidilic acid based adjuvant
UA101385C2 (ru) Иммунологическая композиция, которая в качестве адъюванты содержит сульфолипо-циклодекстрин (sl-cd) и сапонин
IN2014DN08830A (ru)
WO2009128952A3 (en) Compositions of toll-like receptor agonists and papillomavirus antigens and uses thereof
MX2011012347A (es) Vacunas contra virus del herpes simple tipo 2: composiciones y metodos para obtener una respuesta inmunitaria.
MX2019008303A (es) Ácido ribonucleico modificado con nucleósidos para inducir una respuesta inmune contra el virus zika.
WO2006113214A3 (en) Vaccine against pandemic strains of influenza viruses
BRPI1013780B8 (pt) Composição imunogênica útil para imunização contra staphylococcus aureus, seu método de preparação e composição farmacêutica
WO2007067681A3 (en) Immunostimulatory compositions and methods
MX2010002435A (es) Reduccion de infecciones concomitantes en cerdos mediante el uso de antigeno pcv2.
MX2009001412A (es) Vacunas de matriz de proteinas y metodos de hacer y administrar tales vacunas.
MX2009006178A (es) Vacuna contra salmonela.
DK1898948T3 (da) Polyriboinosinsyre-polyribocytidylsyre-baseret adjuvans
MY165831A (en) Methods of reducing virucidal activity in pcv-2 compositions and pcv-2 compositions with a improved immunogenicity
EP2759307A3 (en) Vaccine against Streptococci
MX2009007942A (es) Vacunas basadas en virus del mosaico de la papaya contra salmonella typhi y otros patogenos enterobacterianos.
GEP201706766B (en) Methods and compositions for vaccinating against staphylococcus aureus
BR112023019301A2 (pt) Formulações de vacina de coronavírus
MX2015006970A (es) Composiciones del virus del sindrome reproductor y respiratorio de porcino y sus usos.
SG162817A1 (en) Methods and compositions.to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma
WO2009077577A3 (en) Vaccine antigens from piscirickettsia salmonis
WO2013104995A3 (en) Compositions and methods for treating viral infections
WO2008008541A3 (en) Methods to elicit, enhance and sustain immune responses against mhc class-i restricted epitopes, for prophylactic or therapeutic purposes
WO2012074881A3 (en) Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
TN2009000195A1 (en) Prime boost canine leishmania vaccine